Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif

dc.authorid0000-0003-3667-6902
dc.contributor.authorDemir, Yeliz
dc.contributor.authorTürkeş, Cüneyt
dc.contributor.authorÇavuş, Muhammet Serdar
dc.contributor.authorErdoğan, Musa
dc.contributor.authorMuğlu, Halit
dc.contributor.authorYakan, Hasan
dc.contributor.authorBeydemir, Şükrü
dc.date.accessioned2023-05-25T13:35:14Z
dc.date.available2023-05-25T13:35:14Z
dc.date.issued2023en_US
dc.departmentRektörlük, Rektör
dc.description.abstractNew Schiff base‐bearing thiosemicarbazones (1–13) were obtained from 4‐hydroxy‐3, 5‐dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives.en_US
dc.description.pubmedpublicationidPMID: 36575148en_US
dc.description.sponsorshipBu yayın "Anadolu University, 2102S003" tarafından desteklenmiştir.en_US
dc.identifier.citationDemir Y, Türkeş C, Çavuş MS, Erdoğan M, Muğlu H, Yakan H, Beydemir Ş. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. Arch Pharm (Weinheim). 2023 Apr;356(4):e2200554. doi: 10.1002/ardp.202200554. Epub 2022 Dec 27. PMID: 36575148.en_US
dc.identifier.doi10.1002/ardp.202200554
dc.identifier.issn0365-6233
dc.identifier.issn1521-4184
dc.identifier.issue4en_US
dc.identifier.pmid36575148
dc.identifier.scopus2-s2.0-85145266945
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1002/ardp.202200554
dc.identifier.urihttps://hdl.handle.net/11552/2989
dc.identifier.volume356en_US
dc.identifier.wosWOS:000903773400001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.indekslendigikaynakWoS
dc.indekslendigikaynakWoS - Science Citation Index Expanded
dc.institutionauthorBeydemir, Şükrü
dc.language.isoen
dc.publisherWileyen_US
dc.relation.ispartofArchiv der Pharmazie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDFTen_US
dc.subjectEnzyme Inhibitionen_US
dc.subjectMolecular Dockingen_US
dc.subjectSpectroscopic Elucidationen_US
dc.subjectThiosemicarbazonesen_US
dc.titleEnzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Archiv der Pharmazie - 2022 - Demir - Enzyme inhibition molecular docking and density functional theory studies of new.pdf
Boyut:
4.85 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Yayıncı Kopyası_Makale Dosyası

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: